CRISPR Therapeutics AG (NASDAQ:CRSP)

56.87
Delayed Data
As of Nov 15
 +1.81 / +3.29%
Today’s Change
22.22
Today|||52-Week Range
57.40
+99.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues247.0K5.2M41.0M3.1M
 
 
 
 
 
Depreciation And Amortization127.0K1.0M3.1M3.5M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses25.8M70.3M102.5M158.5M
 
 
 
 
 
Other Operating Expenses0.002.0M0.000.00
 
 
Research And Development12.6M42.2M69.8M113.8M
 
 
 
 
 
Total Operating Expenses26.0M73.3M105.6M162.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.7M-68.1M-64.6M-158.9M
 
 
 
 
 
Extraordinary Credit0.0011.5M0.000.00
 
 
Pre-Tax Equity Earnings0.00-36.5M-1.8M-4.3M
 
 
 
 
Interest Expense On Debt108.0K8.1M0.000.00
 
 
 
Other Expenses16.0K78.5M-197.0K-1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-25.8M-22.7M-66.6M-164.4M
 
 
 
 
 
Income Taxes-7.0K-484.0K-1.7M-553.0K
 
 
 
 
 
Minority Interest-325.0K-25.0K0.000.00
 
 
 
Net Income-25.5M-23.2M-68.4M-165.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS39.4M12.3M40.1M48.0M
 
 
 
 
 
Shares To Calculate EPS Diluted39.4M12.3M40.1M48.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.65-$1.89-$1.71-$3.44
 
 
 
 
 
EPS Diluted-$0.65-$1.89-$1.71-$3.44